Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
NSCLCNSCLC Stage IVNSCLC Stage IIIBNon-Small Cell Lung CancerAdvanced Non-Small Cell Squamous Lung CancerAdvanced Non-Small Cell Lung CancerAdvanced Non-Small Cell Non-Squamous Lung Cancer
Interventions
DRUG

MYTX-011

MYTX-011 will be administered as an intravenous infusion every 21 days.

Trial Locations (55)

100

RECRUITING

National Taiwan University Hospital, Taipei

704

RECRUITING

National Cheng Kung University Hospital, Tainan City

2050

RECRUITING

Chris O'Brien Lifehouse, Camperdown

2148

RECRUITING

Blacktown Hospital, Blacktown

5000

RECRUITING

Queen Elizabeth Hospital, Adelaide

5011

RECRUITING

Cancer Research SA, Adelaide

10016

RECRUITING

NYU Langone Medical Center, New York

15232

RECRUITING

UPMC Hillman Cancer Center, Pittsburgh

21565

RECRUITING

Chungbuk National Univ. Hospital, Incheon

22031

RECRUITING

NEXT Oncology, Fairfax

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

29425

RECRUITING

MUSC Hollings Cancer Center, Charleston

30322

RECRUITING

Winship Cancer Institute, Emory University, Atlanta

37203

RECRUITING

Sarah Cannon Research Institute, Nashville

53226

RECRUITING

Medical College of Wisconsin, Milwaukee

63110

RECRUITING

Washington University School of Medicine in St. Louis, St Louis

68130

RECRUITING

Nebraska Cancer Specialists, Omaha

77030

RECRUITING

MD Anderson Cancer Center, Houston

90095

RECRUITING

UCLA, Los Angeles

92037

RECRUITING

University of California San Diego, La Jolla

92663

RECRUITING

Hoag Memorial Hospital Presbyterian, Newport Beach

98019

RECRUITING

Fred Hutchinson Cancer Center, Seattle

110301

RECRUITING

Taipei Medical University Hospital, Taipei

302058

RECRUITING

National Taiwan University Hospital Hsin-Chu Branch, Zhubei

02114

RECRUITING

Massachusetts General Hospital, Boston

07960

RECRUITING

Atlantic Health System, Morristown

Unknown

RECRUITING

Institut Bergonié-Bordeaux, Bordeaux

RECRUITING

Centre Léon Bérard - Lyon, Lyon

RECRUITING

APHM - Hopital de la Timone, Marseille

RECRUITING

Institut de Cancérologie de l'Ouest (ICO institute)-St Herblain, Nantes

RECRUITING

INSTITUT Curie (lead), Paris

RECRUITING

Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse

RECRUITING

Gustave Roussy Institute, Villejuif

RECRUITING

Kosin Univ. Gospel Hospital, Busan

RECRUITING

Gachon University, Seongnam

RECRUITING

Samsung Medical Center, Seoul

RECRUITING

Severance Hospital, Seoul

RECRUITING

St. Vincent Hospital, Suwon

RECRUITING

Instituto Oncológico Dr Rosell (IOR) - Hospital Univ. Dexeus, Barcelona

RECRUITING

START Barcelona-HM CIOCC Early Phase Program, Barcelona

RECRUITING

Hospital Universitario Ramón y Cajal, Madrid

RECRUITING

START Centro Integral Oncologico Calra Campal, Madrid

RECRUITING

START Madrid-FJD, Hospital Fundación Jiménez Díaz, Madrid

RECRUITING

Hospital Quirónsalud Málaga, Málaga

RECRUITING

Hospital Clinico Universitario de Valencia, Valencia

RECRUITING

Hospital Universitario Lozano Blesa, Zaragoza

RECRUITING

National Taiwan University Cancer Centre, Taipei

RECRUITING

National Taiwan University Cancer Centre, Taipei

RECRUITING

Beatson West of Scotland Cancer Centre, Glasgow

RECRUITING

Newcastle upon Tyne Hospital (NHS), Newcastle

01886

RECRUITING

Seoul National University Hospital, Seoul

RECRUITING

Taichung Veterans General Hospital, Taichung

03080

RECRUITING

National Cancer Center, Seoul

W1T 7HA

RECRUITING

University College London Hospitals NHS Foundation Trust, London

OX3 7LJ

RECRUITING

Churchill Hospital - Oxford University Hospitals, Oxford

Sponsors
All Listed Sponsors
lead

Mythic Therapeutics

INDUSTRY